drugset / Trial / NCT07862595

A Clinical Trial of MK-6916 in Participants With Pain After Bunion Removal Surgery (MK-6916-007)

NCT07862595 ↗

Phase 2 Not yet recruiting 380 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupTriple-blindTreatment

Summary

Researchers are looking for new treatments for pain. While there are many approved treatments for pain, the treatments do not work well for everyone. People can also become addicted to certain pain medicines. Researchers designed a trial medicine called MK-6916 to treat pain. The goal of the trial is to learn if at least 1 dose of MK-6916 works better than placebo to lessen pain. A placebo looks like the trial medicine but has no trial medicine in it. Using a placebo helps researchers better understand the effects of the trial medicine.

Timeline

Start
2026-11-23
Primary completion
2027-06-10
Completion
2027-06-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 325 mg Oral
Comparator Hydrocodone Unknown 5 mg Oral
Subject MK-6916 Unknown 70 mg Oral
Subject MK-6916 Unknown 120 mg Oral
Background Oxycodone Other / unclassified 5 mg Oral

Indications

No indication recorded.